Company: CMND
Filing Date: 2025-10-31
Form Type: 6-K
Source: 0001213900-25-104396
Chunk: 1

Company: Clearmind Medicine Inc.
Filing Date: 2025-10-31
Form: 6-K
Chunk 1
---
 |
| 99.1        |     | Press release titled: “Clearmind Medicine Advances Fight Against                                                      
 Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy” |

<div align='center'>2

SIGNATURES</div>

Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

| Date: October 31, 2025 | Clearmind Medicine, Inc. 
 (Registrant)             
 By:                      | /s/ Adi Zuloff-Shani    |
|:-----------------------|:-------------------------|:------------------------|
|                        | Name:                    | Adi Zuloff-Shani        |
|                        | Title:                   | Chief Executive Officer |

<div align='center'>3</div>